𝔖 Bobbio Scriptorium
✦   LIBER   ✦

m-AMSA AND VP-16 COMBINATIONS IN THE TREATMENT OF ACUTE MYELOID LEUKAEMI

✍ Scribed by J. A. Child; D. R. Norfolk; C. R. Franks; G. Nys

Book ID
114711020
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
115 KB
Volume
65
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I study of VP-16 (etoposide) and a
Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemia
✍ Letendre, Louis ;Hinemann, Vicky ;Hoagland, H. Clark ;Kovach, John S. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 291 KB

Fourteen patients with refractory acute nonlymphocytic leukemia were entered into a doseseeking trial of combination therapy with etoposide and amsacrine given daily for five consecutive days. There were three complete responses lasting 2 months, 3 months, and 10 months and two transient partial rem

Treatment of refractory acute myeloid le
Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: Results of a clinical phase I/II study
✍ Wolfgang Hiddemann; Dieter Urbanitz; Peter Preusser; Wolf Achterrath; Thomas BΓΌc πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 482 KB

Twenty patients with refractory AML were treated with mAMSA and VP 16-2 13 in combination to assess the toxicity and anti-leukemic activity of the two-drug regimen. Refractoriness was defined according to the response to induction therapy consisting of 6-thioguanine, cytosine arabinoside and daunoru